Notably, two WIPI4 residues involved in ATG2 binding are mutated in patients with BPAN, and there is a correlation between the inhibitory effect of these mutations on ATG2 binding and the severity of the disease. This evidence concerns the gene WDR45 and neurodegeneration with brain iron accumulation 5.